Biotech startup scores $20M to develop drug that triggers the immune system to fight cancer by Clare McGrane on November 29, 2017November 30, 2017 at 8:51 am Mavupharma, a biotech startup based in Kirkland, Wash., announced Wednesday that it has raised a $20 million Series A funding round to develop a unique class of drug that enables… Read More